Frontiers in oncology · 2026
Case Report: Rare presentations of glioblastoma: three multifocal and one cerebellar cases highlighting the value of shared clinical experience.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cunha Nídia Maltez, Fernandes Mónica Teotónio, Sanchez Clara Romero, Drago José, Simões Filipa, Ferreira José, Bandarra Daniel, Magalhães Joana, Correia Joaquim Pedro, Luz Paulo
Аннотация
BACKGROUND: Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults, typically presenting as a single supratentorial lesion. Multifocal/multicentric, and infratentorial variants are rare but clinically significant, often mimicking metastatic disease and limiting the feasibility of standard treatment. Their management remains challenging, and dedicated therapeutic guidelines are lacking.
METHODS: We describe four uncommon GBM presentations, three multifocal supratentorial tumors and one cerebellar tumor, and integrate their clinical trajectories with a review of the literature to highlight diagnostic and therapeutic considerations.
RESULTS: Across cases, diagnosis required comprehensive neuroimaging and, in several instances, exclusion of an extracranial primary malignancy. Molecular profiles were consistent with IDH-wildtype GBM. Treatment feasibility varied substantially: one patient was unable to receive tumor-directed therapy because of poor performance status, one discontinued treatment after severe hematologic toxicity, one younger patient with preserved performance status initiated standard chemoradiotherapy, and the cerebellar GBM patient was not eligible for adjuvant therapy because of postoperative deterioration and posterior fossa involvement. Survival was short in three cases, ranging from approximately 50 days to 7.5 months after diagnosis, and was approximately one month in the cerebellar case.
CONCLUSION: Rare presentations of GBM, including multifocal and cerebellar disease, carry substantial diagnostic ambiguity, limited therapeutic options, and a markedly poor prognosis. Early multidisciplinary evaluation, optimized supportive care, and research focused on tailored treatment strategies are urgently needed to improve outcomes in these challenging GBM subtypes.
METHODS: We describe four uncommon GBM presentations, three multifocal supratentorial tumors and one cerebellar tumor, and integrate their clinical trajectories with a review of the literature to highlight diagnostic and therapeutic considerations.
RESULTS: Across cases, diagnosis required comprehensive neuroimaging and, in several instances, exclusion of an extracranial primary malignancy. Molecular profiles were consistent with IDH-wildtype GBM. Treatment feasibility varied substantially: one patient was unable to receive tumor-directed therapy because of poor performance status, one discontinued treatment after severe hematologic toxicity, one younger patient with preserved performance status initiated standard chemoradiotherapy, and the cerebellar GBM patient was not eligible for adjuvant therapy because of postoperative deterioration and posterior fossa involvement. Survival was short in three cases, ranging from approximately 50 days to 7.5 months after diagnosis, and was approximately one month in the cerebellar case.
CONCLUSION: Rare presentations of GBM, including multifocal and cerebellar disease, carry substantial diagnostic ambiguity, limited therapeutic options, and a markedly poor prognosis. Early multidisciplinary evaluation, optimized supportive care, and research focused on tailored treatment strategies are urgently needed to improve outcomes in these challenging GBM subtypes.